|

DO-2 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • DeuterOncology1

Indications

  • Hereditary Renal Papillary Cancer1
  • Refractory Tumor1
  • Adult Solid Tumor1
  • Non-small Cell Carcinoma1
  • Advanced Solid Tumor1

Other1 trial

Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.